Annals of Oncology · 2018 · 631 citations · 12 references
MedicineOncologyPharmacotherapyChemotherapyImmunotherapyMetastasisBreast Cancer PharmacotherapyImmune Checkpoint InhibitorsMetastatic Breast CancerMetastatic Cancer ManagementMetastatic Disease TreatmentTargeted TherapyBreast Cancer ChemotherapyComplete Response AssessmentMetastatic Breast Cancer TreatmentPartial Response AssessmentPd-l1 BlockadePembrolizumab TherapyRecist CriteriaSafety Profile Characterization
12
Molecular portraits of human breast tumours
Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Peter Schmid, Sylvia Adams, Hope S. Rugo et al. · New England Journal of Medicine · 2018 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17
Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation
Mark E. Robson, Seock‐Ah Im, Elżbieta Senkus et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text
Medicine, Oncology, Pharmacology +16